This medical device report (mdr) is being submitted by smith & nephew, inc., (b)(4), as part of a remedial action following the issuance of the 483 issued march 26, 2015 to smith & nephew, inc., fei no: (b)(4).This mdr is being filed in an abundance of caution.We are submitting one (1) initial, 30 day report, medwatch fda form 3500a.As described in our response to the 483, smith & nephew, inc., (b)(4) is engaging an independent clinician to evaluate whether loss of distension could be considered a serious injury per 21 c.F.R § 803.3.Based on the analysis provided by this independent clinician, smith & nephew, inc., (b)(4) will determine whether such events do meet the reporting requirements of 21 c.F.R.Part 803.In addition, in response to the 483, smith & nephew, inc., (b)(4) is in the process of improving its mdr assessment process and reporting procedures to help ensure reports are appropriately filed with the agency.Included within these improvements is a retrospective review of complaints not previously reported to the agency to verify reporting decisions in accordance with the improved process.Accordingly, smith & nephew, inc., (b)(4) may be retrospectively filing additional events, if required, to the agency.(b)(4).
|